More than three million people are diagnosed with cancer each year in Europe.
It's likely this number will increase by at least 65% over the next 20 years. Given this predicted increase, the need for personalised cancer care is becoming ever more crucial.
Our eSMART system will give patients continual support both during and after chemotherapy while allowing them to remain in the comfort of their own homes.
The eSMART (Electronic Symptom Management System Remote Technology) project is a pioneering research project that aims to transform cancer care and significantly reduce healthcare costs. It will do this by enabling cancer care clinicians to monitor patients undergoing chemotherapy treatment for breast, bowel and blood cancers via mobile phone.